KKKlaus-Peter Knobeloch

Klaus-Peter Knobeloch

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Klaus-Peter Knobeloch has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Ivan Horak

    Leibniz Institut für Molekulare Pharmakologie, Abteilung Molekulare Genetik, Krahmerstr. 6, D-12207 Berlin, Germany

    2 shared publications
  • Sandra Niendorf

    Leibniz Institut für Molekulare Pharmakologie, Krahmerstr. 6, D-12207 Berlin, Germany

    2 shared publications
  • Agnes Kisser

    Leibniz Institut für Molekulare Pharmakologie, Abteilung Molekulare Genetik, Krahmerstr. 6, D-12207 Berlin, Germany

    1 shared publication
  • Alexander Oksche

    Institut für Pharmakologie, Charité, Universitätsmedizin Berlin, Campus Benjamin Franklin, D-14195 Berlin, Germany

    1 shared publication
  • Anna Osiak

    Institute of Molecular Pharmacology, Department of Molecular Genetics, Krahmerstr. 6, 12207 Berlin, Germany

    1 shared publication
  • Hubert Schorle

    Department of Developmental Pathology, Institute of Pathology, University Hospital Bonn, Bonn, Germany

    1 shared publication

Latest Publications

  • Essential Role of Ubiquitin-Specific Protease 8 for Receptor Tyrosine Kinase Stability and Endocytic Trafficking In Vivo

    by Sandra Niendorf, Alexander Oksche, Agnes Kisser, Jürgen Löhler, Marco Prinz, Hubert Schorle, Stephan Feller, Marc Lewitzky, Ivan Horak, Klaus-Peter Knobeloch

    Posttranslational modification by ubiquitin controls multiple cellular functions and is counteracted by the activities of deubiquitinating enzymes. UBPy (USP8) is a growth-regulated ubiquitin isopeptidase that interacts with the HRS-STAM complex. Using Cre-loxP-mediated gene targeting in mice, we show that lack of UBPy results in embryonic lethality, whereas its conditional inactivation in adults causes fatal liver failure. The defect is accompanied by a strong reduction or absence of several growth factor receptor tyrosine kinases (RTKs), like epidermal growth factor receptor, hepatocyte growth factor receptor (c-met), and ERBB3. UBPy-deficient cells exhibit aberrantly enlarged early endosomes colocalizing with enhanced ubiquitination and have reduced levels of HRS and STAM2. Congruently immortalized cells gradually stop proliferation upon induced deletion of UBPy. These results unveil a central and nonredundant role of UBPy in growth regulation, endosomal sorting, and the control of RTKs in vivo.


  • ISG15, an Interferon-Stimulated Ubiquitin-Like Protein, Is Not Essential for STAT1 Signaling and Responses against Vesicular Stomatitis and Lymphocytic Choriomeningitis Virus

    by Anna Osiak, Olaf Utermöhlen, Sandra Niendorf, Ivan Horak, Klaus-Peter Knobeloch

    ISG15 is an interferon-induced ubiquitin-like modifier which can be conjugated to distinct, but largely unknown, proteins. ISG15 has been implicated in a variety of biological activities, which encompass antiviral defense, immune responses, and pregnancy. Mice lacking UBP43 (USP18), the ISG15-deconjugating enzyme, develop a severe phenotype with brain injuries and lethal hypersensitivity to poly(I:C). It has been reported that an augmented conjugation of ISG15 in the absence of UBP43 induces prolonged STAT1 phosphorylation and that the ISG15 conjugation plays an important role in the regulation of JAK/STAT and interferon signaling (O. A. Malakhova, M. Yan, M. P. Malakhov, Y. Yuan, K. J. Ritchie, K. I. Kim, L. F. Peterson, K. Shuai, and D. E. Zhang, Genes Dev. 17:455-460, 2003). Here, we report that ISG15−/− mice are viable and fertile and display no obvious abnormalities. Lack of ISG15 did not affect the development and composition of the main cellular compartments of the immune system. The interferon-induced antiviral state and immune responses directed against vesicular stomatitis virus and lymphocytic choriomeningitis virus were not significantly altered in the absence of ISG15. Furthermore, interferon- or endotoxin-induced STAT1 tyrosine-phosphorylation, as well as expression of typical STAT1 target genes, remained unaffected by the lack of ISG15. Thus, ISG15 is dispensable for STAT1 and interferon signaling.